vTv Therapeutics Inc. (VTVT)
NASDAQ·Healthcare·Biotechnology
$33.20
+2.26%
Mkt Cap $95.58M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$51.33
Range $47.00 – $58.00
Implied Upside
+54.6%
Consensus $51.33 vs current $33.20
NASDAQ·Healthcare·Biotechnology
$33.20
+2.26%
Mkt Cap $95.58M
No recent rating data.
Price Target (3 analysts)
$51.33
Range $47.00 – $58.00
+54.6%
Consensus $51.33 vs current $33.20